Publication

GRIN1 mutation associated with intellectual disability alters NMDA receptor trafficking and function

Downloadable Content

Persistent URL
Last modified
  • 03/05/2025
Type of Material
Authors
    Wenjuan Chen, Emory UniversityChristine Shieh, University of California Los AngelesSharon Swanger, Emory UniversityAnel Tankovic, Emory UniversityMargaret Au, Cedars-Sinai Medical CenterMarianne McGuire, Baylor College of MedicineMichele Tagliati, Cedars-Sinai Medical CenterJohn M. Graham, Cedars-Sinai Medical CenterSuneeta Madan-Khetarpal, University of PittsburghStephen Traynelis, Emory UniversityHongjie Yuan, Emory UniversityTyler Mark Pierson, Cedars-Sinai Medical Center
Language
  • English
Date
  • 2017-06-01
Publisher
  • Nature Publishing Group: Open Access Hybrid Model Option B
Publication Version
Copyright Statement
  • © 2017 The Japan Society of Human Genetics. All rights reserved.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1434-5161
Volume
  • 62
Issue
  • 6
Start Page
  • 589
End Page
  • 597
Grant/Funding Information
  • TMP and CS were funded by the Cedars-Sinai institutional funding program and the Cedars-Sinai Diana and Steve Marienhoff Fashion Industries Guild Endowed Fellowship in Pediatric Neuromuscular Diseases.
  • During this work, WC was supported by the Xiangya-Emory Medical Schools Visiting Student Program; HY was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development, NIH-R01HD082373, by the Emory +Children’s Pediatric Center Seed Grant Program, by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000454, by NIH HHSN268201400169P; SFT was supported by NIH-NINDS R01NS036654, R24NS092989 and R01NS092989.
Abstract
  • N-methyl-d-aspartate receptors (NMDARs) play important roles in brain development and neurological disease. We report two individuals with similar dominant de novo GRIN1 mutations (c.1858 G > A and c.1858 G > C; both p.G620R). Both individuals presented at birth with developmental delay and hypotonia associated with behavioral abnormalities and stereotypical movements. Recombinant NMDARs containing the mutant GluN1-G620R together with either GluN2A or GluN2B were evaluated for changes in their trafficking to the plasma membrane and their electrophysiological properties. GluN1-G620R/GluN2A complexes showed a mild reduction in trafficking, a ∼2-fold decrease in glutamate and glycine potency, a strong decrease in sensitivity to Mg 2+ block, and a significant reduction of current responses to a maximal effective concentration of agonists. GluN1-G620R/GluN2B complexes showed significantly reduced delivery of protein to the cell surface associated with similarly altered electrophysiology. These results indicate these individuals may have suffered neurodevelopmental deficits as a result of the decreased presence of GluN1-G620R/GluN2B complexes on the neuronal surface during embryonic brain development and reduced current responses of GluN1-G620R-containing NMDARs after birth. These cases emphasize the importance of comprehensive functional characterization of de novo mutations and illustrates how a combination of several distinct features of NMDAR expression, trafficking and function can be present and influence phenotype.
Author Notes
  • Correspondence: Dr TM Pierson, Departments of Pediatrics and Neurology, and the Board of Governors Regenerative Medicine Institute, Cedars-Sinai Medical Center, 8700 Beverly Blvd., ASHP 8401, Los Angeles, CA 90048, USA. tyler.pierson@cshs.org
Keywords
Research Categories
  • Biology, Neuroscience
  • Biology, Genetics
  • Health Sciences, Pharmacology

Tools

Relations

In Collection:

Items